Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017, Article ID 8182020, 12 pages
https://doi.org/10.1155/2017/8182020
Research Article

Detection of Urine Metabolites in a Rat Model of Chronic Fatigue Syndrome before and after Exercise

1College of Arts and Sciences, Shanghai Maritime University, Shanghai 201306, China
2Laboratory of Nutrition and Hygiene, Shaanxi Normal University, Xi’an 710119, China
3School of Sports, Hebei Normal University, Shijiazhuang 050090, China

Correspondence should be addressed to Aiping Chi; moc.qq@178686183

Received 17 November 2016; Accepted 5 March 2017; Published 22 March 2017

Academic Editor: Isabelle Chevalot

Copyright © 2017 Changzhuan Shao et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. G. Son, “A case of chronic fatigue syndrome improved by traditional Korean medicine,” Integrative Medicine Research, vol. 2, no. 1, pp. 32–35, 2013. View at Publisher · View at Google Scholar
  2. K. Fukuda, S. E. Straus, I. Hickie, M. C. Sharpe, J. G. Dobbins, and A. Komaroff, “The chronic fatigue syndrome: a comprehensive approach to its definition and study,” Annals of Internal Medicine, vol. 121, no. 12, pp. 953–959, 1994. View at Publisher · View at Google Scholar · View at Scopus
  3. L. Steele, J. G. Dobbins, K. Fukuda et al., “The epidemiology of chronic fatigue in San Francisco,” American Journal of Medicine, vol. 105, no. 3A, pp. 611–614, 1998. View at Google Scholar · View at Scopus
  4. S. Wessely, T. Chalder, S. Hirsch, P. Wallace, and D. Wright, “The prevalence and morbidity of chronic fatigue and chronic fatigue syndrome: a prospective primary care study,” American Journal of Public Health, vol. 87, no. 9, pp. 1449–1455, 1997. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Lee, H. Yu, Y. Wing et al., “Psychiatric morbidity and illness experience of primary care patients with chronic fatigue in Hong Kong,” The American Journal of Psychiatry, vol. 157, no. 3, pp. 380–384, 2000. View at Publisher · View at Google Scholar · View at Scopus
  6. X. Q. Wang, T. Takahashi, S. Zhu et al., “Effect of Hochu-ekki-to (TJ-41), a Japanese herbal medicine, on daily activity in a murine model of chronic fatigue syndrome,” Evidence-Based Complementary and Alternative Medicine, vol. 1, no. 2, pp. 203–206, 2004. View at Publisher · View at Google Scholar
  7. A. C. Logan and C. Wong, “Chronic fatigue syndrome: oxidative stress and dietary modifications,” Alternative Medicine Review, vol. 6, no. 5, pp. 450–459, 2001. View at Google Scholar · View at Scopus
  8. A. S. Papadopoulos and A. J. Cleare, “Hypothalamic-pituitary-adrenal axis dysfunction in chronic fatigue syndrome,” Nature Reviews Endocrinology, vol. 8, no. 1, pp. 22–32, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. H. Rosenblum, Y. Shoenfeld, and H. Amital, “The common immunogenic etiology of chronic fatigue syndrome: from infections to vaccines via adjuvants to the ASIA syndrome,” Infectious Disease Clinics of North America, vol. 25, no. 4, pp. 851–863, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. D. Wagner, R. Nisenbaum, C. Heim, J. F. Jones, E. R. Unger, and W. C. Reeves, “Psychometric properties of the CDC symptom inventory for assessment of chronic fatigue syndrome,” Population Health Metrics, vol. 3, article 8, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. N. Guo, D. Yang, X. Wang, J. Dai, M. Wang, and Y. Lei, “Metabonomic study of chronic heart failure and effects of Chinese herbal decoction in rats,” Journal of Chromatography A, vol. 1362, pp. 89–101, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. Y. Hua, W. Xue, M. Zhang, Y. Wei, and P. Ji, “Metabonomics study on the hepatoprotective effect of polysaccharides from different preparations of Angelica sinensis,” Journal of Ethnopharmacology, vol. 151, no. 3, pp. 1090–1099, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. V. Lalremruta and G. S. Prasanna, “Evaluation of protective effect of Aegle marmelos Corr. in an animal model of chronic fatigue syndrome,” Indian Journal of Pharmacology, vol. 44, no. 3, pp. 351–356, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. A. K. Sachdeva, A. Kuhad, and K. Chopra, “Epigallocatechin gallate ameliorates behavioral and biochemical deficits in rat model of load-induced chronic fatigue syndrome,” Brain Research Bulletin, vol. 86, no. 3-4, pp. 165–172, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. T. Takahashi, F. Yu, S.-J. Zhu et al., “Beneficial effect of Brewers' yeast extract on daily activity in a murine model of chronic fatigue syndrome,” Evidence-Based Complementary and Alternative Medicine, vol. 3, no. 1, pp. 109–115, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Chi, C. Kang, Y. Zhang et al., “Immunomodulating and antioxidant effects of polysaccharide conjugates from the fruits of Ziziphus Jujube on Chronic Fatigue Syndrome rats,” Carbohydrate Polymers, vol. 122, pp. 189–196, 2015. View at Publisher · View at Google Scholar · View at Scopus
  17. A.-P. Chi, J.-P. Chen, Z.-Z. Wang, Z.-Y. Xiong, and Q.-X. Li, “Morphological and structural characterization of a polysaccharide from Gynostemma pentaphyllum Makino and its anti-exercise fatigue activity,” Carbohydrate Polymers, vol. 74, no. 4, pp. 868–874, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. D. B. Cook, G. Lange, J. Deluca, and B. H. Natelson, “Relationship of brain MRI abnormalities and physical functional status in chronic fatigue syndrome,” International Journal of Neuroscience, vol. 107, no. 1-2, pp. 1–6, 2001. View at Publisher · View at Google Scholar · View at Scopus
  19. M. J. Heins, H. Knoop, and G. Bleijenberg, “The role of the therapeutic relationship in cognitive behaviour therapy for chronic fatigue syndrome,” Behaviour Research and Therapy, vol. 51, no. 7, pp. 368–376, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. M. J. Heins, H. Knoop, J. Lobbestael, and G. Bleijenberg, “Childhood maltreatment and the response to cognitive behavior therapy for chronic fatigue syndrome,” Journal of Psychosomatic Research, vol. 71, no. 6, pp. 404–410, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. C. C. Gandhi, R. M. Kelly, R. G. Wiley, and T. J. Walsh, “Impaired acquisition of a Morris water maze task following selective destruction of cerebellar purkinje cells with OX7-saporin,” Behavioural Brain Research, vol. 109, no. 1, pp. 37–47, 2000. View at Publisher · View at Google Scholar · View at Scopus
  22. B. Evengård, R. S. Schacterle, and A. L. Komaroff, “Chronic fatigue syndrome: new insights and old ignorance,” Journal of Internal Medicine, vol. 246, no. 5, pp. 455–469, 1999. View at Publisher · View at Google Scholar · View at Scopus
  23. S. P. Van der Werf, J. B. Prins, J. H. M. M. Vercoulen, J. W. M. Van der Meer, and G. Bleijenberg, “Identifying physical activity patterns in chronic fatigue syndrome using actigraphic assessment,” Journal of Psychosomatic Research, vol. 49, no. 5, pp. 373–379, 2000. View at Publisher · View at Google Scholar · View at Scopus
  24. K. K. McCully and B. H. Natelson, “Impaired oxygen delivery to muscle in chronic fatigue syndrome,” Clinical Science, vol. 97, no. 5, pp. 603–608, 1999. View at Publisher · View at Google Scholar · View at Scopus
  25. D. Buchwald and A. L. Komaroff, “Review of laboratory findings for patients with chronic fatigue syndrome,” Reviews of Infectious Diseases, vol. 13, pp. S12–S18, 1991. View at Publisher · View at Google Scholar · View at Scopus
  26. S. V. Kamzolova, N. V. Shishkanova, I. G. Morgunov, and T. V. Finogenova, “Oxygen requirements for growth and citric acid production of Yarrowia lipolytica,” FEMS Yeast Research, vol. 3, no. 2, pp. 217–222, 2003. View at Publisher · View at Google Scholar · View at Scopus
  27. C. M. Pariante, “Chronic fatigue syndrome and the immune system: ‘findings in search of meanings’,” Brain, Behavior, and Immunity, vol. 23, no. 3, pp. 325–326, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. H. Prinsen, I. J. M. de Vries, R. Torensma et al., “Humoral and cellular immune responses after influenza vaccination in patients with chronic fatigue syndrome,” BMC Immunology, vol. 13, article 71, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. E. W. Brenu, K. J. Ashton, M. Van Driel et al., “Cytotoxic lymphocyte microRNAs as prospective biomarkers for Chronic Fatigue Syndrome/Myalgic Encephalomyelitis,” Journal of Affective Disorders, vol. 141, no. 2-3, pp. 261–269, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. M. A. Fletcher, K. J. Maher, and N. G. Klimas, “Natural killer cell function in chronic fatigue syndrome,” Clinical and Applied Immunology Reviews, vol. 2, no. 2, pp. 129–139, 2002. View at Publisher · View at Google Scholar · View at Scopus
  31. J. Zou, J. Yuan, S. Lv, and J. Tu, “Effects of exercise on behavior and peripheral blood lymphocyte apoptosis in a rat model of chronic fatigue syndrome,” Journal of Huazhong University of Science and Technology—Medical Science, vol. 30, no. 2, pp. 258–264, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. P. Newsholme, K. Bender, A. Kiely, and L. Brennan, “Amino acid metabolism, insulin secretion and diabetes,” Biochemical Society Transactions, vol. 35, no. 5, pp. 1180–1186, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. P. De Becker, N. McGregor, and K. De Meirleir, “Possible triggers and mode of onset of chronic fatigue syndrome,” Journal of Chronic Fatigue Syndrome, vol. 10, no. 2, pp. 3–18, 2002. View at Publisher · View at Google Scholar · View at Scopus
  34. C. Heim, D. Wagner, E. Maloney et al., “Early adverse experience and risk for chronic fatigue syndrome: results from a population-based study,” Archives of General Psychiatry, vol. 63, no. 11, pp. 1258–1266, 2006. View at Publisher · View at Google Scholar · View at Scopus
  35. N. G. Klimas and A. O. Koneru, “Chronic fatigue syndrome: inflammation, immune function, and neuroendocrine interactions,” Current Rheumatology Reports, vol. 9, no. 6, pp. 482–487, 2007. View at Publisher · View at Google Scholar · View at Scopus
  36. A. T. White, A. R. Light, R. W. Hughen, T. A. Vanhaitsma, and K. C. Light, “Differences in metabolite-detecting, adrenergic, and immune gene expression after moderate exercise in patients with chronic fatigue syndrome, patients with multiple sclerosis, and healthy controls,” Psychosomatic Medicine, vol. 74, no. 1, pp. 46–54, 2012. View at Publisher · View at Google Scholar · View at Scopus
  37. A. González-Usano, O. Cauli, A. Agusti, and V. Felipo, “Pregnenolone sulfate restores the glutamate-nitric-oxide-cGMP pathway and extracellular GABA in cerebellum and learning and motor coordination in hyperammonemic rats,” ACS Chemical Neuroscience, vol. 5, no. 2, pp. 100–105, 2014. View at Publisher · View at Google Scholar · View at Scopus
  38. A. Kreinin, N. Bawakny, and M. S. Ritsner, “Adjunctive pregnenolone ameliorates the cognitive deficits in recent-onset schizophrenia,” Clinical Schizophrenia & Related Psychoses, vol. 1, no. 1, pp. 25–31, 2014. View at Google Scholar
  39. R. Wheatland, “Chronic ACTH autoantibodies are a significant pathological factor in the disruption of the hypothalamic-pituitary-adrenal axis in chronic fatigue syndrome, anorexia nervosa and major depression,” Medical Hypotheses, vol. 65, no. 2, pp. 287–295, 2005. View at Publisher · View at Google Scholar · View at Scopus
  40. N. J. Haughey, V. V. R. Bandaru, M. Bae, and M. P. Mattson, “Roles for dysfunctional sphingolipid metabolism in Alzheimer's disease neuropathogenesis,” Biochimica et Biophysica Acta (BBA)—Molecular and Cell Biology of Lipids, vol. 1801, no. 8, pp. 878–886, 2010. View at Publisher · View at Google Scholar · View at Scopus
  41. K. Iwata, H. Matsuzaki, T. Miyachi et al., “Investigation of the serum levels of anterior pituitary hormones in male children with autism,” Molecular Autism, vol. 2, no. 1, article 16, 2011. View at Publisher · View at Google Scholar · View at Scopus
  42. C. Bode and M. H. Gräler, “Immune regulation by sphingosine 1-phosphate and its receptors,” Archivum Immunologiae et Therapiae Experimentalis, vol. 60, no. 1, pp. 3–12, 2012. View at Publisher · View at Google Scholar · View at Scopus
  43. A. J. Melendez, “Sphingosine kinase signalling in immune cells: potential as novel therapeutic targets,” Biochimica et Biophysica Acta, vol. 1784, no. 1, pp. 66–75, 2008. View at Publisher · View at Google Scholar · View at Scopus
  44. A. Cheshire, D. Ridge, L. Clark, and P. White, “Why patients with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis improve or deteriorate with graded exercise therapy,” Journal of Psychosomatic Research, vol. 85, p. 59, 2016. View at Publisher · View at Google Scholar